| |
Company
Roster
|
|
Total
Insiders : |
50 |
|
|
|
Total
Direct Shares :
|
17,014,885 |
|
|
Total
Indirect Shares :
|
29,413,761 |
| |
%
Held by Insiders:
|
66.18% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Kelley Shannon T |
General Counsel |
2026-01-20 |
8,481 |
|
0 |
| Taub Rebecca |
Director |
2026-01-20 |
453,351 |
2026-01-20 |
655,540 |
| Thakkar Rita |
Chief Accounting Officer |
2026-01-15 |
2,398 |
2026-01-15 |
0 |
| Friedman Paul A |
Director |
2026-01-09 |
187,164 |
2026-01-09 |
655,540 |
| Sibold William John |
President and CEO, Director |
2025-12-04 |
150,074 |
2023-09-11 |
0 |
| Dier Mardi |
EVP and CFO |
2025-12-02 |
10,440 |
|
0 |
| Huntsman Carole |
Chief Commercial Officer |
2025-11-21 |
10,032 |
2023-11-20 |
0 |
| Levy Richard S |
Director |
2025-11-13 |
21,197 |
2017-08-21 |
0 |
| Bate Kenneth |
Director |
2025-11-05 |
2,627 |
2024-04-01 |
0 |
| Brennan Daniel J. |
Director |
2025-08-01 |
967 |
2025-08-01 |
0 |
| Fouse Jacqualyn A |
Director |
2025-06-20 |
1,097 |
2025-03-10 |
0 |
| Daly James M |
Director |
2025-06-20 |
2,627 |
2024-04-01 |
0 |
| Soergel David |
Chief Medical Officer |
2025-05-15 |
7,545 |
2025-05-15 |
0 |
| Waltermire Robert E. |
Senior VP, Chief Pharma Dev. |
2025-03-05 |
5,789 |
2023-01-16 |
0 |
| Craves Fred B |
Director |
2024-12-03 |
360,076 |
2024-12-03 |
23,471 |
| Baker Julian |
|
2024-06-25 |
0 |
2025-06-20 |
1,796,261 |
| Lynch Brian Joseph |
|
2024-01-23 |
17,691 |
2024-01-23 |
530 |
| Howarth Alex G. |
|
2024-01-23 |
18,737 |
2023-01-16 |
0 |
| Baker Brothers Life Sciences Lp |
|
2023-11-14 |
0 |
2025-08-20 |
1,947,968 |
| Sukhija Remy |
Chief Commercial Officer |
2023-01-16 |
15,001 |
2022-12-23 |
0 |
| Bay City Capital Fund Iv Co Invesment Fund Lp |
10% Owner |
2021-12-03 |
1,261 |
2021-12-03 |
0 |
| Milligan David V |
Director |
2018-11-21 |
0 |
2018-09-18 |
0 |
| Bay City Capital Fund Llc |
Director, 10% Owner |
2018-06-11 |
0 |
2018-06-11 |
113,472 |
| Schneebaum Marc R |
Chief Financial Officer |
2018-06-11 |
41,668 |
2014-12-08 |
0 |
| Rieder Wendy E |
Former SVP, Gen. Counsel |
2016-07-22 |
17,730 |
|
0 |
| Schor Chen |
Former President and CEO, Director |
2016-07-22 |
37,178 |
2014-12-08 |
0 |
| Morenstein Scott D |
Director |
2016-01-01 |
17,857 |
2016-01-01 |
0 |
| Gollust Keith R |
Director |
2015-12-14 |
401,764 |
2015-12-14 |
1,714,169 |
| Kovner Bruce |
Director, 10% Owner |
2015-12-08 |
3,092,677 |
2015-12-08 |
18,019,580 |
| Wilson Robert N |
Director |
2015-07-01 |
760,936 |
|
0 |
| Reardon William S |
Director |
2015-07-01 |
49,392 |
|
0 |
| Whitaker Anne Clem |
President and CEO, Director |
2014-09-02 |
500,000 |
2014-09-02 |
0 |
| Mcmahon Arthur |
Officer |
2014-01-03 |
12,829 |
|
0 |
| Bernitz Steven B |
SVP, Corporate Development |
2013-12-18 |
25,000 |
2013-12-18 |
0 |
| Singh Amar |
Sr. VP, Chief Business Officer |
2013-12-02 |
15,161 |
2010-11-29 |
0 |
| Bahcall Safi R |
President and CEO, Director |
2013-11-13 |
2,053,135 |
2013-11-13 |
480,000 |
| Kufe Donald W |
Director |
2013-07-01 |
25,748 |
2012-07-01 |
0 |
| Vukovic Vojo |
SVP, Chief Medical Officer |
2013-06-05 |
35,249 |
|
0 |
| Ramachandra Sumant |
President, R&D |
2013-03-11 |
75,000 |
2013-03-11 |
0 |
| Ehrlich Keith S |
VP, Fin. and Admin., CFO |
2012-03-01 |
17,573 |
|
0 |
| Koya Keizo |
Sr. VP, Drug Development |
2012-03-01 |
12,999 |
|
0 |
| Chen Lan Bo |
Director |
2011-12-06 |
666,262 |
2011-12-06 |
1,436,283 |
| Bailey Michael P |
Sr. VP, Chief Comm. Officer |
2010-08-05 |
29,627 |
2008-08-04 |
0 |
| Chadwick Jeremy G |
Sr. VP, Pgm Mgmt and Clin Ops |
2009-01-05 |
15,853 |
|
0 |
| Williams Martin D |
Sr. VP, Business Dev., CBO |
2007-11-16 |
0 |
2007-02-09 |
0 |
| Folkman Judah |
Director |
2007-06-30 |
7,676 |
|
0 |
| Caxton Corp |
10% Owner |
2007-02-09 |
7,761,716 |
|
0 |
| Jacobson Eric W |
Sr. VP, Research and CMO |
2007-02-09 |
25,300 |
|
0 |
| Barsoum James G |
Officer |
2007-02-05 |
40,000 |
|
0 |
| Chen Lin Huey |
10% Owner |
|
0 |
2009-11-20 |
2,570,947 |
|
3.27 (0.65%) 
